The role involves providing scientific and strategic leadership for multiple late-stage clinical programs within the Duchenne muscular dystrophy portfolio.
Base: $222,400 - $278,000 per year; Bonus/Equity: Not specified; Benefits: Comprehensive wellness and caregiver support included
Must-have
Nice-to-have
Must be authorized to work in the U.S.